Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo. Jyotsana N, Sharma A, Chaturvedi A, Budida R, Scherr M, Kuchenbauer F, Lindner R, Noyan F, Sühs KW, Stangel M, Grote-Koska D, Brand K, Vornlocher HP, Eder M, Thol F, Ganser A, Humphries RK,0, Ramsay E, Cullis P, Heuser M. Ann Hematol. 2019 May 18. doi: 10.1007/s00277-019-03713-y. Read abstract.